← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
torben jörgensen
Styrelseledamot | Styrelseordförande
Profile key: se|torben jörgensen
Purchase history
- Companies traded
- 4
- Purchases · 12M
- 3
- Purchases · 24M
- 5
- Average purchase
- SEK 666,889
- Gross purchase value
- SEK 3,334,445
- Last purchase
- 2026-10-01
- Completed 20D events
- 3.0
- Outcome status
- INSUFFICIENT_SAMPLE
Latest company: Genovis AB
Companies: Boule Diagnostics AB | Genovis A/B | Genovis AB | Integrum AB
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 4Small sample | 100.0% (4/4) | 50.0% (2/4) | -0.3% | +2.4% | -1.2% |
| 20D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +3.3% | +1.5% | -10.5% |
| 60D | 3Small sample | 100.0% (3/3) | 0.0% (0/3) | -20.5% | -23.1% | -33.6% |
| 120D | 3Small sample | 100.0% (3/3) | 0.0% (0/3) | -30.3% | -33.1% | -39.1% |
Research patterns
- First purchase in 12M
- 3/3
- Large purchase ≥ €100k
- 0/3
- Cluster buying · 15D
- 3/4
- Buying the dip · ≥20% below prior 52W high
- 4/4
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.